Low-Dose Rapamycin Alleviates Clinical Symptoms of Fatigue and PEM in ME/CFS Patients via Improvement of Autophagy: A Pilot Study
Published: 10 September 2025| Version 1 | DOI: 10.17632/k78d4cgcyx.1
Contributors:
Brian Ruan, , Brooke Gile, , Description
Questionnaire, biomarker, and analysis data pertaining to the ME/CFS rapamycin trial.
Files
Institutions
- Cornell University
- University of Wisconsin Milwaukee
Categories
Sirolimus, Mammalian Target of Rapamycin, Autophagy, Chronic Fatigue Syndrome, Patient-Reported Outcome, Myalgic Encephalomyelitis